| Precision Therapeutics is a CLIA-certified clinical laboratory |
Breast Cancer
Breast cancer is a cancer that forms in the tissues of the breast. Although it occurs in both males and females, cases in males are rare. In the United States alone, 1 in 8 women will be diagnosed with breast cancer. Tumors usually begin in the ducts or lobules of the breast and if left untreated can spread to other parts of the body (metastasize). While breast cancer results from a genetic abnormality, the growth of tumors is not always due to inheritance. Approximately 10 percent of breast cancer cases are “inherited” from one’s parents and the other 90 percent are a result of the aging process and other factors.
Breast Cancer Treatment Options
Breast cancer treatment options are determined by a cancer’s particular stage and development. Treatment options include surgery, chemotherapy, radiation therapy, hormonal therapy and targeted therapy. In most cases, surgery is the first stage of treatment (lumpectomy, mastectomy or lymph node removal). Surgeries are often followed by chemotherapy and/or radiation therapy treatments to destroy any remaining cancer cells post operation.
Breast Cancer and ChemoFx®
For breast cancer patients receiving chemotherapy, whether as adjuvant chemotherapy, primary chemotherapy or combination chemotherapy, ChemoFx® can assist physicians in selecting personalized cancer treatment plans. Physicians can use ChemoFx® as a guide by testing multiple chemotherapy drugs on a patient's cancer cells before choosing one for their patient, giving patients a powerful advantage in their fight against cancer. For more information on ChemoFx® , visit http://www.chemofx.com.
Information for this webpage was gathered from the following websites:
http://www.breastcancer.org
http://www.cancer.gov
www.chemofx.com